Ledger.Open graph →
SEC Form D · filed September 22, 2021

BioVaxys Technology Corp

Offering
$249K
Sold
$249K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

James Passin · New York, NYExec · DirectorDavid Wang · Redwood City, CADirectorLachlan Mcleod · Vancouver, British Columbia, CanadaExecKenneth Kovan · New York, NYExecDaren Hermiston · Vancouver, British Columbia, CanadaDirectorJames Passin · New York, NYExec · DirectorDavid Wang · Los Angeles, CADirectorLachlan Mcleod · Vancouver, British Columbia, CanadaExecKenneth Kovan · New York, NYExecDaren Hermiston · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗